• Angus BJ, Smith MD, Suputtamongkol Y et al. (2000) Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs. intermittent bolus injection in septicaemic melioidosis. British Journal of Pharmacology 49, 184191.
  • Currie BJ, Fisher DA, Howard DM et al. (2000) Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clinical Infectious Diseases 31, 981986.
  • Funk D, Gray J & Plourde PJ (2001) Two-year trends of peripherally inserted central catheter-line complications at a tertiary-care hospital: role of nursing expertise. Infection Control and Hospital Epidemiology 22, 377379.
  • Loewenthal MR, Dobson PM, Starkey RE et al. (2002) The peripherally inserted central catheter (PICC): a prospective study of its natural history after cubital fossa insertion. Anaesthesia and Intensive Care 30, 2124.
  • Moureau N, Poole S, Murdock MA, Gray SM & Semba CP (2002) Central venous catheters in home infusion care: outcomes analysis in 50 470 patients. Journal of Vascular and Interventional Radiology 13, 10091016.
  • Servais H & Tulkens PM (2001) Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients. Antimicrobial Agents and Chemotherapy 45, 26432647.
  • Stendal TL, Klem W, Tonnesen HH & Kjonniksen I (1998) Drug stability and pyridine generation in ceftazidime injection stored in an elastomeric infusion device. American Journal of Health-System Pharmacy 55, 683685.
  • Viaene E, Chanteux H, Servais H, Mingeot-Leclercq MP & Tulkens PM (2002) Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units). Antimicrobial Agents and Chemotherapy 46, 23272332.